These findings provide the first evidence of LDLRAP1‐associated ARH in Tunisia and highlight the genetic heterogeneity of FH, emphasising the importance of integrating molecular, structural and functional analyses for accurate diagnosis, personalised management and early prevention. The gene discussed is LDLRAP1; the disease is familial hyperaldosteronism.